Peterson Amy C. - Insider Non-Derivative Transactions at CytomX Therapeutics, Inc. (CTMX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Mar 16, 2023, Peterson Amy C.'s relationship to CytomX Therapeutics, Inc. (CTMX) is Officer (EVP, Chief Development Officer), and currently has 58,433 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other CTMX insiders.
Data Source: SEC.
Peterson Amy C. - Insider Non-Derivative Transactions at CTMX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Mar 17, 2023 | Sell -- (Common Stock) | 4257 | 1.98 | 58433 |